PALONOSETRON DRX palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

palonosetron hydrochloride, Quantity: 280 microgram (Equivalent: palonosetron, Qty 250 microgram)

Mevcut itibaren:

Dr Reddys Laboratories Australia Pty Ltd

INN (International Adı):

Palonosetron hydrochloride

Farmasötik formu:

Injection, solution

Kompozisyon:

Excipient Ingredients: mannitol; sodium acetate trihydrate; water for injections; hydrochloric acid; sodium hydroxide

Uygulama yolu:

Intravenous Infusion

Paketteki üniteler:

1 x 5 mL vial

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Ürün özeti:

Visual Identification: A clear colourless solution free from visible extraneous matters.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2016-07-13